Anthocyanins in Chronic Diseases: The Power of Purple

Nutrients. 2022 May 23;14(10):2161. doi: 10.3390/nu14102161.

Abstract

Anthocyanins are mainly purple-coloured phenolic compounds of plant origin that as secondary metabolites are important in plant survival. Understanding their health benefits in humans requires sourcing these unstable compounds in sufficient quantities at a reasonable cost, which has led to improved methods of extraction. Dark-coloured fruits, cereals and vegetables are current sources of these compounds. The range of potential sustainable sources is much larger and includes non-commercialised native plants from around the world and agri-waste containing anthocyanins. In the last 5 years, there have been significant advances in developing the therapeutic potential of anthocyanins in chronic human diseases. Anthocyanins exert their beneficial effects through improvements in gut microbiota, oxidative stress and inflammation, and modulation of neuropeptides such as insulin-like growth factor-1. Their health benefits in humans include reduced cognitive decline; protection of organs such as the liver, as well as the cardiovascular system, gastrointestinal tract and kidneys; improvements in bone health and obesity; and regulation of glucose and lipid metabolism. This review summarises some of the sources of anthocyanins and their mechanisms and benefits in the treatment of chronic human diseases.

Keywords: agri-waste; anthocyanins; gut microbiota; inflammation; oxidative stress; tropical fruit.

Publication types

  • Review

MeSH terms

  • Anthocyanins* / chemistry
  • Chronic Disease
  • Edible Grain / chemistry
  • Fruit / chemistry
  • Humans
  • Vegetables* / chemistry

Substances

  • Anthocyanins

Grants and funding

This research received no external funding.